This quality standard covers diagnosing and managing inflammatory bowel disease (Crohn’s disease and ulcerative colitis) in adults, young people and children. It describes high-quality care in priority areas for improvement.
We’ve produced new guidance on gastrointestinal and liver conditions treated with drugs affecting the immune response to follow during the COVID-19 pandemic. This is relevant to statements 1, 2 and 4 in this quality standard and may help to support using the quality standard during this time.
Quality standards help you improve the quality of care you provide or commission. Find out how to use quality standards and how we develop them. We check our quality standards every August to make sure they are up to date.